MedTrace Logo

Autologous Bone Marrow Mesenchymal Stem Cell Transplantation for Chronic Stroke

NCT01714167 · Status: UNKNOWN · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2015-06-08

No results posted yet for this study

Summary

Stroke is one of the leading causes of disability in the world, and stem cell - transplantation provides a promising approach for rehabilitation. The main objective of this study is to evaluate the efficacy of the intracerebral injection of autologous bone marrow mesenchymal stem cells in patients with chronic stroke.

Conditions

Interventions

GENETIC

intracerebral stem cell transplantation

Intracerebral transplantation of autologous bone marrow mesenchymal stem cell, 2-4 million stem cells per patient

Sponsors & Collaborators

  • University of North Texas Health Science Center

    collaborator OTHER

  • Wenzhou Medical University

    lead OTHER

Principal Investigators

  • Kunlin Jin, M.D., Ph.D. · University of North Texas Health Science Center

  • Qichuan Zhuge, M.D. · First Affiliated Hospital of Wenzhou Medical University

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-06-30
Primary Completion
2015-10-31
Completion
2015-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01714167 on ClinicalTrials.gov